We are live on ! Find out more
MB

MPM BioImpact Portfolio holdings

AUM $1.29B
1-Year Est. Return 141.72%
This Fund
S&P 500
This Quarter Est. Return
+20.37%
1 Year Est. Return
+141.72%
3 Year Est. Return
+440.65%
5 Year Est. Return
+290.21%
10 Year Est. Return
–
AUM
$1.29B
AUM Growth
+$421M
Cap. Flow
+$290M
Cap. Flow %
22.39%
Top 10 Hldgs %
49.01%
Holding
49
New
11
Increased
20
Reduced
8
Closed
8

Top Buys

1
AKTS
Aktis Oncology
AKTS
+$93.9M
2
DBVT
DBV Technologies
DBVT
+$88.1M
3
CORT icon
Corcept Therapeutics
CORT
+$36.9M
4
TVTX icon
Travere Therapeutics
TVTX
+$33.9M
5
CYTK icon
Cytokinetics
CYTK
+$31.8M

Top Sells

1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$56.4M
2
PTCT icon
PTC Therapeutics
PTCT
+$32.7M
3
PTGX icon
Protagonist Therapeutics
PTGX
+$17.4M
4
CRVS icon
Corvus Pharmaceuticals
CRVS
+$17.1M
5
VTYX
Ventyx Biosciences
VTYX
+$14.8M

Sector Composition

1 Healthcare 100%

No holdings matched the selected filter criteria.

1 2

Similar funds

MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
ACM
Alta Capital Management Salt Lake City, Utah $1.29B AUM 17.57% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
COCM
Charter Oak Capital Management Portsmouth, New Hampshire $1.29B AUM 13.93% 1-Year Est. Return
MA
MONECO Advisors Fairfield, Connecticut $1.29B AUM 18.01% 1-Year Est. Return